← Leaderboards
Mack Clarence Mitchell
Cleveland Clinic Lerner Com-Cwru
$3,742,457
Attributed
$8,603,939
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,603,939 · 2
By mechanism
U01$8,603,939 · 2
Top collaborators
- Craig J Mcclain8 shared
- Arthur J Mccullough8 shared
- Gyongyi Szabo8 shared
- E Sherwood Brown2 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Jianguo Wu$931,657
- Srinivasan Dasarathy$21,059,442
- Abhijit Duggal$68,269
- David Streem$354,195
Others in their field
Top investigators on “Zinc”
- Robert O Wright · Brigham And Women'S Hospital$31,447,581
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$30,980,110
- David Heimbrook · Leidos Biomedical Research, Inc.$21,781,988
- George M Church · Harvard University (Medical School)$18,964,918
- Traci Clemons · The Emmes Company, Llc$16,914,864
- James L Riley · University Of Pennsylvania$15,240,970
Research focus
ZincRandomizedResourcesAnakinraFda ApprovedTranslational ResearchLiverAlcoholic HepatitisMorbidity - Disease RateResearch DesignClinical TrialsStandard Of CareAlcoholic Liver DiseasesLiver DiseasesTranslational StudyPathogenesisAdrenal Cortex HormonesBaseSamplingInflammationPilot ProjectsSeveritiesPentoxifyllinePharmaceutical Preparations
Grant awards (16)
Integrated therapies for alcohol use and ALD (ITAALD) Network â UTSW Clinical Center$360,800
U01 · FY2025 · AA · contact PI
Integrated therapies for alcohol use and ALD (ITAALD) Network â UTSW Clinical Center$360,800
U01 · FY2024 · AA · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 8/9$368,172
U01 · FY2022 · AA · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 8/9$379,324
U01 · FY2021 · AA · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 8/9$379,324
U01 · FY2020 · AA · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 8/9$379,324
U01 · FY2019 · AA · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 8/9$368,172
U01 · FY2018 · AA · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trial and Observational Studies 8/9$7,114
U01 · FY2018 · AA · contact PI
Novel Therapies for Alcoholic Hepatitis$526,938
U01 · FY2017 · AA
Novel Therapies for Alcoholic Hepatitis$1,114,312
U01 · FY2016 · AA
Novel Therapies for Alcoholic Hepatitis$1,060,741
U01 · FY2015 · AA
Novel Therapies for Alcoholic Hepatitis$29,291
U01 · FY2015 · AA
Novel Therapies for Alcoholic Hepatitis$1,060,741
U01 · FY2014 · AA
Novel Therapies for Alcoholic Hepatitis$1,011,775
U01 · FY2013 · AA
Novel Therapies for Alcoholic Hepatitis$75,000
U01 · FY2013 · AA
Novel Therapies for Alcoholic Hepatitis$1,122,111
U01 · FY2012 · AA